Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Susan P. Perrine, MD
Researcher Professor of Pediatrics, Medicine, Pharmacology and Experimental Therapeutics
Boston University School of Medicine
72 E. Concord St Instructional (L)
Boston, Massachusetts, United States
Her research is dedicated to identifying targeted mechanisms and therapeutics that modulate endogenous genes to treat serious diseases, such as reactivating the genes for fetal globin to ameliorate sickle cell disease and beta thalassemia, through inhibiting specific repressors. With Dr. Douglas Faller, she is applying a therapeutic to induce viral EBV genes and then use anti-viral agents to destroy lymphomas in which EBV resides. She also works on mechanisms and therapies to correct blood cell deficiencies.
Research Interests: Translational targeted therapeutics, molecular mechanisms of globin gene expression, pharmaceutical development
Clinical Interests: Hemoglobinopathies, thalassemias, viral lymphomas, cytopenias
+myBinderRelated Content
-
Froedtert Hospital, Sickle Cell ClinicSickle cell disease (SCD) is a genetic d...
-
Carolyn Rowley, PhDDr. Rowley is the Founder and Executive ...
-
Kwaku Ohene-Frempong, MD (Remembering)We are devastated to learn of the death ...
-
The Regional Comprehensive Sickle Cell Center at Robert Wood Johnson Medical SchoolThe Division of Hematology provides spec...
-
Comparing Sickle Cell Disease Acute Pain Management in the Pediatric and Adult Emergency DepartmentBackground: Vasoocclusive pain leading ...
-
Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospita...Introduction: Acute vaso-occlusive crisi...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
